| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0036 | 1 |